Novadip Biosciences Funding: $88M Raised, Series B (2022)
Novadip Biosciences is based in Leuven, Belgium. It has raised $88M in total funding. Latest round: Series B.
Novadip Biosciences funding overview
Novadip Biosciences is based in Leuven, Belgium. Novadip Biosciences has raised $88M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2022. The round record for Novadip Biosciences runs through 2022; nothing later has been disclosed. Investors on record include New Science Venture, European Investment Bank, Belgian funds. 3 distinct backers are named across the disclosed rounds.
Novadip Biosciences at a glance
Total raised
$88M
Latest round
Series B
Latest round date
November 2022
Headquarters
Leuven, Belgium
Notable investors
New Science Venture, European Investment Bank, Belgian funds
Frequently asked about Novadip Biosciences funding
How much has Novadip Biosciences raised?
Novadip Biosciences has raised $88M in total disclosed funding across the rounds on record.
Who has invested in Novadip Biosciences?
New Science Venture, European Investment Bank, Belgian funds are named among the investors backing Novadip Biosciences.
What was the latest Novadip Biosciences funding round?
The most recent disclosed round is a Series B, announced in November 2022.
Where is Novadip Biosciences based?
Novadip Biosciences is based in Leuven, Belgium.
When did Novadip Biosciences last raise?
The last disclosed Novadip Biosciences round closed in November 2022 at Series B.
We update the Novadip Biosciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Leuven and their backers are listed below.
